Agree To Buy Regeneron Pharmaceuticals At $195, Earn 8.9%

Investors considering a purchase of Regeneron Pharmaceuticals ( REGN) stock, but cautious about paying the going market price of $293.78/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $195 strike, which has a bid at the time of this writing of $17.30. Collecting that bid as the premium represents a 8.9% return against the $195 commitment, or a 6.7% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

START SLIDESHOW:
Top YieldBoost Puts of the Nasdaq 100 »

Selling a put does not give an investor access to REGN's upside potential the way owning shares would, because the put seller only ends up owning shares in the scenario where the contract is exercised. And the person on the other side of the contract would only benefit from exercising at the $195 strike if doing so produced a better outcome than selling at the going market price. ( Do options carry counterparty risk? This and six other common options myths debunked). So unless Regeneron Pharmaceuticals, Inc. sees its shares fall 33.3% and the contract is exercised (resulting in a cost basis of $177.70 per share before broker commissions, subtracting the $17.30 from $195), the only upside to the put seller is from collecting that premium for the 6.7% annualized rate of return.

Below is a chart showing the trailing twelve month trading history for Regeneron Pharmaceuticals, Inc., and highlighting in green where the $195 strike is located relative to that history:

Loading+chart++2013+TickerTech.com

The chart above, and the stock's historical volatility, can be a helpful guide in combination with fundamental analysis to judge whether selling the January 2015 put at the $195 strike for the 6.7% annualized rate of return represents good reward for the risks. We calculate the trailing twelve month volatility for Regeneron Pharmaceuticals, Inc. (considering the last 249 trading day closing values as well as today's price of $293.78) to be 42%. For other put options contract ideas at the various different available expirations, visit the REGN Stock Options page of StockOptionsChannel.com.

In mid-afternoon trading on Monday, the put volume among S&P 500 components was 934,735 contracts, with call volume at 1.21M, for a put:call ratio of 0.77 so far for the day, which is unusually high compared to the long-term median put:call ratio of .65. In other words, there are lots more put buyers out there in options trading so far today than would normally be seen, as compared to call buyers. Find out which 15 call and put options traders are talking about today.

null

If you liked this article you might like

Handling Your Finances at Any Age: Cramer's 'Mad Money' Recap (Monday 2/12/18)

Handling Your Finances at Any Age: Cramer's 'Mad Money' Recap (Monday 2/12/18)

Volatility Reigns Supreme: Cramer's 'Mad Money' Recap (Thursday 2/8/18)

Volatility Reigns Supreme: Cramer's 'Mad Money' Recap (Thursday 2/8/18)

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Anthem, A.O. Smith, Tableau Software: 'Mad Money' Lightning Round

Anthem, A.O. Smith, Tableau Software: 'Mad Money' Lightning Round

Cramer Calls It a Market Reset: 'Mad Money' Recap (Monday 2/5/18)

Cramer Calls It a Market Reset: 'Mad Money' Recap (Monday 2/5/18)